| Company Name: |
cjbscvictory |
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
|
| | Proteinase, Bothrops atrox serine Basic information |
| Product Name: | Proteinase, Bothrops atrox serine | | Synonyms: | Proteinase, Bothrops atrox serine;Bothrops venom proteinase;Botropase;BATROXOBIN, FROM BOTHROPS ATROX;Batroxobin (jan/inn);D03352;Defibrase (tn) | | CAS: | 9039-61-6 | | MF: | | | MW: | 0 | | EINECS: | 232-918-4 | | Product Categories: | | | Mol File: | Mol File | ![Proteinase, Bothrops atrox serine Structure]() |
| | Proteinase, Bothrops atrox serine Chemical Properties |
| form | Solid | | color | White to off-white |
| | Proteinase, Bothrops atrox serine Usage And Synthesis |
| Originator | Defibrase,Serono,W. Germany,1982 | | Uses | Defibrase, deinagkistrodonacutus is a proteolytic enzyme extraction of Agkistrodon halys venom. Defibrase can be used for degradation of fibrinogen. Defibrase can exacerbate myosin-induced EAM (experimental autoimmune myositis). Defibrase can be used for degradation of fibrinogen. Defibrase is commonly used for research of acute ischemic cerebrovascular disease, thromboangiitis obliterans, deep phlebitis and sudden deafness[1]. | | Manufacturing Process | The process for preparing the enzyme composition comprises treating an
aqueous solution of the snake venom at a pH of about 4 to 6 with phenol or a
phenol derivative in order to precipitate an insoluble complex containing the
active venom fraction and decomposing the complex in order to release the
thrombinlike enzyme composition. | | Therapeutic Function | Hemostatic | | References | [1] Wen-Jing L, et al. A new modified animal model of myosin-induced experimental autoimmune myositis enhanced by defibrase. Arch Med Sci. 2015 Dec 10;11(6):1272-8. DOI:10.5114/aoms.2015.52883 |
| | Proteinase, Bothrops atrox serine Preparation Products And Raw materials |
|